Direkt zum Inhalt
Merck

Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization.

Bioorganic & medicinal chemistry letters (2002-09-25)
Steven D Linton, Donald S Karanewsky, Robert J Ternansky, Ning Chen, Xian Guo, Kathy G Jahangiri, Vincent J Kalish, Steven P Meduna, Edward D Robinson, Brett R Ullman, Joe C Wu, Brian Pham, Lalitha Kodandapani, Robert Smidt, Jose-Luis Diaz, Lawrence C Fritz, U von Krosigk, Silvio Roggo, Albert Schmitz, Kevin J Tomaselli
ZUSAMMENFASSUNG

A new structural class of broad spectrum caspase inhibitors was optimized for its activity against caspases 1, 3, 6, 7, and 8. The most potent compound had low nanomolar broad spectrum activity, in particular, single digit nanomolar inhibitory activity against caspase 8.